A GWAS study on liver function test using eMERGE network participants

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Namjou, Bahram ^a,b   Marsolo, Keith ^a,b   Lingren, Todd ^a,b   Ritchie, Marylyn D ^c   Verma, Shefali S ^c   Cobb, Beth L ^a   Perry, Cassandra ^d   Kitchner, Terrie E ^e   Brilliant, Murray H ^e   Peissig, Peggy L ^e   Borthwick, Kenneth M ^f   Williams, Marc S ^f   Grafton, Jane ^g   Jarvik, Gail P ^h   Holm, Ingrid A ^d,i   Harley, John B ^a,b,j  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e MARSHFIELD CLINIC   (United States)

^f GEISINGER HEALTH SYSTEM   (United States)

^g GROUP HEALTH RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANION TRANSPORT PROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B1; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B3; GLUCURONOSYLTRANSFERASE; UGT1A1 ENZYME;

AGE DISTRIBUTION; ANCESTRY GROUP; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO SYSTEM; CEREBROVASCULAR DISEASE; CHROMOSOME 2Q; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; EUROPEAN; FEMALE; GALLBLADDER DISEASE; GENE; GENE CLUSTER; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; GENOMICS; GENOTYPE; GILBERT DISEASE; HEMOLYTIC ANEMIA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERBILIRUBINEMIA; ICD-9; LINEAR REGRESSION ANALYSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PHENOME WIDE ASSOCIATION; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; QUALITY CONTROL; SEX DIFFERENCE; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SLCO1B1 GENE; SLCO1B3 GENE; TDRP GENE; TOXIC HEPATITIS; UGT1A GENE; ZMYND8 GENE; ADULT; BLOOD; CASE CONTROL STUDY; CAUCASIAN; CHILD; DEMOGRAPHY; ELECTRONIC HEALTH RECORD; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

ADULT; ALKALINE PHOSPHATASE; BILIRUBIN; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; DEMOGRAPHY; ELECTRONIC HEALTH RECORDS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; GLUCURONOSYLTRANSFERASE; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER FUNCTION TESTS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84946934930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138677     Document Type: Article

References (43)

1. Bathum L, Petersen HC, Rosholm JU, Hyltoft Petersen P, Vaupel J, Christensen K. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem. 2001; 47:81-87. PMID: 11148181
2. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.N Engl J Med. 1995; 333:1171-5. PMID: 7565971
3. Lampe JW, Bigler J, Horner N K, Potter J D. UDPglucuronosyltransferase (UGT1A128 andUGT1A62) polymorphisms in Caucasians and Asians: Relationships to serum bilirubin concentrations. Pharmacogenetics.1999; 9, 341-349. PMID: 10471066
4. Premawardhena A, Fisher CA, Liu YT, Verma I C, De Silva S, Arambepola M, et al.The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications. Blood Cells Mol Dis,2003; 31, 98-101. PMID: 12850492
5. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, et al. Association between the UGT1A128 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation. 2006; 114, 1476-1481. PMID: 17000907
6. Zucker SD, Qin X, Rouster SD, Yu F, Green RM, Keshavan P, et al. Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci USA.2001; 98: 12671-12676. PMID: 11606755
7. Innocenti F, Vokes EE, Ratain MJ. Irinogenetics: what is the right star? J Clin Oncol. 2006; 24:2221-4. PMID: 16636339
8. Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, Sasaoka Y, et al. Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 1993; 197:1239-44. PMID: 8280139
9. Sugatani J, Yamakawa K, Yoshinari K, Machida T, Takagi H, Mori M, et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun 2002; 292:492-7. PMID: 11906189
10. Jinno H, Tanaka-Kagawa T, Hanioka N, Saeki M, Ishida S, Nishimura T, et al. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D. Drug Metab Dispos 2003; 31:108-13. PMID: 12485959
11. Gagné JF, Montminy V, Belanger P, Journault K, Gaucher G, Guillemette C. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 2002; 62:608-17. PMID: 12181437
12. Kim JY, Cheong HS, Park BL, Kim LH, Namgoong S, Kim JO, et al. Comprehensive variant screening of the UGT gene family.Yonsei Med J. 2014; 55:232-9. PMID: 24339312 doi: 10.3349/ymj.2014.55.1. 232
13. Sneitz N, Bakker CT, de Knegt RJ, Halley DJ, Finel M, Bosma PJ. Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants. Hum Mutat. 2010; 31:52-59. PMID: 19830808 doi: 10.1002/humu.21133
14. Sampietro M, Iolascon A. Molecular pathology of Crigler-Najjar type I and II and Gilbert's syndromes. Haematologica.1999; 84, 150-157. PMID: 10091414
15. McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med. Genomics 2011; 4:13 doi: 10.1186/1755-8794-4-13 PMID: 21269473
16. Johnson AD, Kavousi M, Smith AV, Chen MH, Dehghan A, Aspelund T, et al. Genome-wide association meta-analysis for total serum bilirubin levels.Hum Mol Genet. 2009; 18:2700-10. PMID: 19414484 doi: 10.1093/hmg/ddp202
17. Bielinski SJ, Chai HS, Pathak J, Talwalkar JA, Limburg PJ, Gullerud RE, et al. Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels. Mayo Clin Proc. 2011; 86:606-14. doi: 10.4065/mcp.2011.0178 PMID: 21646302
18. Dai X, Wu C, He Y, Gui L, Zhou L, Guo H, et al. A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population. Genet Epidemiol. 2013; 37:293-300. doi: 10.1002/gepi.21711 PMID: 23371916
19. Kang TW, Kim HJ, Ju H, Kim JH, Jeon YJ, Lee HC, et al. Genome-wide association of serum bilirubin levels in Korean population. Hum Mol Genet. 2010; 19:3672-8. doi: 10.1093/hmg/ddq281 PMID: 20639394
20. Sanna S, Busonero F, Maschio A, McArdle PF, Usala G, Dei M, et al. common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet. 2009; 18:2711-8. doi: 10.1093/hmg/ddp203 PMID: 19419973
21. Chen G, Ramos E, Adeyemo A, Shriner D, Zhou J, Doumatey AP, et al. UGT1A1 is a major locus influencing bilirubin levels in African Americans. Eur J Hum Genet. 2012; 20:463-8. doi: 10.1038/ejhg. 2011.206 PMID: 22085899
22. Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet. 2008; 83:520-8. doi: 10.1016/j.ajhg.2008.09.012 PMID: 18940312
23. Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet. 2011; 43:1131-8. doi: 10.1038/ng.970 PMID: 22001757
24. Nelson D, Yoshida EM, Paulson MS, Hengen PN, Ge D, Kanwar B, et al. Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.Antivir Ther. 2014; 19:679-86. doi: 10.3851/IMP2747 PMID: 24503447
25. Verma SS, de Andrade M, Tromp G, Kuivaniemi H, Pugh E, Namjou-Khales B, et al. Imputation and quality control steps for combining multiple genome-wide datasets.Front Genet. 2014; 5:370. doi: 10. 3389/fgene.2014.00370 PMID: 25566314
26. Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda). 2011; 1, 457-70.
27. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38, 904-9. PMID: 16862161
28. Rasmussen-Torvik LJ, Stallings SC, Gordon AS, Almoguera B, Basford MA, Bielinski SJ, et al. Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.Clin Pharmacol Ther. 2014; 96:482-9. doi: 10.1038/clpt. 2014.137 PMID: 24960519
29. Berk PD, Korenblat KM. Approach to the patient with jaundice or abnormal liver test results. In: Goldman L, Ausiello D, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 149.
30. Pratt DS. Liver chemistry and function tests. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders Elsevier;2010: chap 73.
31. Namjou B, Marsolo K, Caroll RJ, Denny JC, Ritchie MD, Verma SS, et al. Phenome-wide association study (PheWAS) in EMR-linked pediatric cohorts, genetically links PLCL1 to speech language development and IL5-IL13 to Eosinophilic Esophagitis.Front Genet. 2014 Nov 18; 5:401. doi: 10.3389/fgene. 2014.00401 PMID: 25477900
32. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007; 81, 559-75. PMID: 17701901
33. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26: 2336-2337. doi: 10.1093/bioinformatics/btq419 PMID: 20634204
34. Rahim F, Galehdari H, Mohammadi-As J, Saki N. Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.Genet Res Int. 2013; 2013:546909. PMID: 23997956 doi: 10.1155/2013/546909
35. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels.Hum Mol Genet. 2010; 19:1863-72. doi: 10.1093/hmg/ddq061 PMID: 20167578
36. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes.Hum Mol Genet. 2010; 19:1856-62. doi: 10.1093/hmg/ddq057 PMID: 20147318
37. Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta 1998; 1406: 267-273 PMID: 9630669
38. Hirano K, Matsumoto H, Tanaka T, Hayashi Y, Iino S, Domar U, et al. Specific assays for human alkaline phosphatase isozymes. Clin Chim Acta1987; 166:265-273.
39. Bayer PM, Hotschek H, Knoth E: Intestinal alkaline phosphatase and the ABO blood group system-a new aspect. Clin Chim Acta 1980; 108:81-87. PMID: 7449139
40. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble Eselectin. Arterioscler Thromb Vasc Biol. 2009; 29:1958-67. doi: 10.1161/ATVBAHA.109.192971 PMID: 19729612
41. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.Nat Genet. 2011; 43:333-8. doi: 10.1038/ng.784 PMID: 21378990
42. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008; 28:166-172. PMID: 17975120
43. Vítek L. Does hyperbilirubinemia protect from coronary heart disease? Am J Cardiol. 2001; 88:1218.